Showing 541-550 of 20372 results for "".
Challenging the Misconception That T1D Is a Childhood-Onset Disease
https://reachmd.com/programs/diabetes-discourse/challenging-the-misconception-that-t1d-is-a-childhood-onset-disease/16257/What proportion of patients with type 1 diabetes are being diagnosed well into adulthood? It might be more than you think.Interventions Targeting Impaired Glucose Tolerance
https://reachmd.com/programs/diabetes-discourse/interventions-targeting-impaired-glucose-tolerance/5010/The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San DChoosing Between Insulin and Incretin Therapies
https://reachmd.com/programs/diabetes-discourse/choosing-between-insulin-and-incretin-therapies/6170/When should healthcare professionals treating patients with type 2 diabetes consider using insulin or incretin treatment or both? Join host Dr. Steven Edelman and his guest, president-elect of the American Diabetes Association and professor of medicine at Tulane University, Dr. Vivian Fonseca, as thInsulin-Like Effects on Exercising Muscles
https://reachmd.com/programs/focus-on-sports-medicine/insulin-like-effects-on-exercising-muscles/3899/Dr. Laurie Goodyear, a senior investigator and head of the section on metabolism at the Joslin Diabetes Center in Boston, discusses with host Dr. Larry Kaskel how exercise impedes the development of type 2 diabetes. Tune in to hear the implications of Dr. Goodyear's research on exercise and how it wIncretin-Based Advances in Obesity and T2D Care
https://reachmd.com/programs/diabetes-discourse/incretin-advances-obesity/57025/For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales shares key updates from the 2026 American Diabetes AsIs a Low-Carb, High-Fat Diet the Key to Diabetic Management?
https://reachmd.com/programs/clinicians-roundtable/is-a-low-carb-high-fat-diet-the-key-to-diabetic-management/10040/Dr. Sarah Hallberg discusses how a simple change in diet can lead to improved blood sugar levels and better management of diabetes.Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease
https://reachmd.com/programs/diabetes-discourse/understanding-dapagliflozin-examining-its-use-in-chronic-kidney-disease/12251/Can a treatment option used for type 2 diabetes help those with chronic kidney disease?Coping Strategies for Patients Growing up With Chronic Illness
https://reachmd.com/programs/clinicians-roundtable/coping-strategies-for-patients-growing-up-with-chronic-illness/3412/Better technology and treatments mean that people with serious childhood illnesses such as cystic fibrosis and type one diabetes are reaching adulthood in unprecedented numbers. That means they are also struggling with college, relationships, fertility and employment. Laurie Edwards, a health journOptimizing Anti-VEGF Selection in Diabetic Macular Edema
https://reachmd.com/programs/eye-on-ocular-health/optimizing-anti-vegf-selection-in-diabetic-macular-edema/60933/Choosing the right anti-VEGF therapy is an important part of optimizing long-term outcomes for patients with diabetic macular edema (DME). Discover how to select the right therapy, incorporate longer-acting agents into practice, and balance durability and long-term disease management with Dr. MichaeExploring COVID-19 in Diabetes: A Look at Disease Management & Risk
https://reachmd.com/programs/diabetes-discourse/exploring-covid-19-in-diabetes-a-look-at-disease-management-risk/12585/Should patients with diabetes be concerned about getting the COVID-19 vaccine?